Christian Itin at UKBIO19 (Endpoints News)
January 6, 2021 07:11 AM EST
People

Au­to­lus buck­les down, chop­ping 20% of staff and seek­ing part­ner for a lead CAR-T pro­gram

Amber Tong

Au­to­lus Ther­a­peu­tics showed up at the vir­tu­al ES­MO con­fer­ence just a few months ago with plen­ty of good things to say about AU­TO3, its …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Pfiz­er look­ing to sell hos­pi­tal drugs unit — re­ports

As­traZeneca CEO reaf­firms com­mit­ment to Chi­na fol­low­ing ex­ec­u­tive's de­ten­tion

'Ex­per­tise is a re­al thing': FDA com­mis­sion­er warns of po­lit­i­cal risk to agency

Mer­ck, As­traZeneca tout Phase 3 win for can­cer-turned-rare dis­ease drug

No­var­tis pays $150M up­front to Schrödinger in new drug deal, ramps up soft­ware use

sponsored

What Will It Take to Re­verse Fi­bro­sis in Pa­tients with Ad­vanced MASH?

A service from the Financial Times